Treatment of advanced primary liver carcinoma using intermittent intra-arterial nitrogen mustard.
D002759:Adenoma, Bile Duct / Q000188:drug therapy; D000792:Angiography; D002277:Carcinoma / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002445:Celiac Artery; D005260:Female; D006465:Hemoperitoneum / Q000209:etiology; D006499:Hepatic Artery; D006801:Humans; D007269:Injections, Intra-Arterial; D008099:Liver / Q000473:pathology; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D012422:Rupture, Spontaneous / Q000139:chemically induced / Q000150:complications
D008466:Mechlorethamine